Next-generation sequencing study validates a core principle behind the CureMatch technology SAN DIEGO, CA – February 16, 2017 – CureMatch, the developer of a decision support platform for combination therapy in cancer, today announced that research from their co-founder and Chief Medical Advisor, Dr. Razelle Kurzrock, was selected by the American Society of Clinical Oncology […]
This webpage is strictly reserved for healthcare professionals. Please confirm that you are a healthcare professional.
Otherwise, you will be redirected to the institutional part of this website.
Thank you for your understanding.